Hiroaki Nagashima (H Nagashima)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cell death & disease

AJNR. American journal of neuroradiology

Massachusetts General Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Massachusetts General Hospital Apr 01 2018

United States

research Fellow :: Neurosurgery

Publications

Takashi Sasayama, Takeshi Hamada, Kazuhiro Tanaka, Hiroaki Nagashima, Shunsuke Yamanishi, Takehiko Ueyama
Potential of GSPT1 as a novel target for glioblastoma therapy. Cell death & disease 15 (8) (2024)
Takashi Sasayama, Takeshi Hamada, Kazuhiro Tanaka, Hiroaki Nagashima, Shunsuke Yamanishi, Takehiko Ueyama
Potential of GSPT1 as a novel target for glioblastoma therapy. Cell death & disease 15 (8) (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Takashi Sasayama, Takeshi Hamada, Kazuhiro Tanaka, Hiroaki Nagashima, Shunsuke Yamanishi, Takehiko Ueyama
Potential of GSPT1 as a novel target for glioblastoma therapy. Cell death & disease 15 (8) (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Yuichi Fujita, Takashi Sasayama, Kazuhiro Tanaka, K Kyotani, Hiroaki Nagashima, Masaaki Kohta, Hidehito Kimura, Atsushi Fujita, Eiji Kohmura
DWI for Monitoring the Acute Response of Malignant Gliomas to Photodynamic Therapy. AJNR. American journal of neuroradiology 40 (12) (2019)

Hiroaki Nagashima.css-eqlu8i{font-size:small;padding-left:4px;} (H Nagashima)

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroaki Nagashima (H Nagashima)